MedPath

Moxetero

Brand Name: Moxetero

Generic Name: Moxifloxacin (as hydrochloride)

Active
Registration Number

DRP-6896

Dosage Form

Film-Coated Tablet

Issuance Date

February 2, 2022

Expiry Date

March 12, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength400 mg
PackagingAlu/alu blister pack x 10's (Box of 100's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antibacterials (Fluoroquinolones)
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Moxifloxacin (as hydrochloride)Active
Monograph: Moxifloxacin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform